The current status of lithium in psychiatry.
D000208:Acute Disease; D001714:Bipolar Disorder / Q000188:drug therapy; D002746:Chlorpromazine / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy; D005260:Female; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D006852:Hydrochlorothiazide / Q000627:therapeutic use; D066298:In Vitro Techniques; D008094:Lithium / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy*; D010919:Placebos; D011293:Premenstrual Syndrome / Q000188:drug therapy; D011600:Psychopharmacology; D012008:Recurrence; D013960:Thyroid Function Tests; D013961:Thyroid Gland / Q000187:drug effects; D014481:United States
D010919:Placebos; D006852:Hydrochlorothiazide; D008094:Lithium; D006220:Haloperidol; D002746:Chlorpromazine